Notch signalling in adult neurons: A potential target for microtubule stabilization

Therapeutic Advances in Neurological Disorders

Volumn 6, Issue 6, 2013, Pages 375-385

  Bonini, Sara Anna ^a   Ferrari Toninelli, Giulia ^a   Montinaro, Mery ^a   Memo, Maurizio ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

cytoskeleton; microtubule stabilization; neurodegeneration; Notch; Spastin; structural plasticity

Indexed keywords

DAVUNETIDE; DISHEVELLED PROTEIN; GAMMA SECRETASE; NEUROGENIN 3; NOTCH RECEPTOR; NOTCH1 RECEPTOR; PACLITAXEL; PROTEINASE ACTIVATED RECEPTOR 1; SPASTIN; TAU PROTEIN; WNT PROTEIN;

ALZHEIMER DISEASE; BLEEDING; CELL ACTIVATION; CELL FATE; CELL MATURATION; CELL PROLIFERATION; CLINICAL TRIAL (TOPIC); DYSPHAGIA; FEVER; GASTROINTESTINAL DISEASE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; IMMUNOREACTIVITY; MEMBRANE STABILIZATION; MICROTUBULE; MICROTUBULE ASSEMBLY; MILD COGNITIVE IMPAIRMENT; MITOSIS SPINDLE; MULTIPLE SCLEROSIS; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVE FIBER DEGENERATION; NERVE FIBER GROWTH; NERVE FIBER TRANSPORT; NEURITE; NEUROPROTECTION; NEUTROPENIA; NONHUMAN; NOTCH PATHWAY; OVARY DISEASE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN PROCESSING; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; SKIN BRUISING;

EID: 84887848354     PISSN: 17562856     EISSN: 17562864     Source Type: Journal    
DOI: 10.1177/1756285613490051     Document Type: Article

References (113)

1. Ahmad I. Zaqouras P. Artavanis-Tsakonas S. (1995) Involvement of Notch-1 in mammalian retinal neurogenesis: association of Notch-1 activity with both immature and terminally differentiated cells. Mech Dev 53:73–85.
2. Almeida-Souza L. Timmerman V. Janssens S. (2011) Microtubule dynamics in the peripheral nervous system: a matter of balance. Bioarchitecture 1: 267–270.
3. Andrieux A. Salin P. Schweitzer A. Bégou M. Pachoud B. Brun P. et al. (2006) Microtubule stabilizer ameliorates synaptic function and behavior in a mouse model for schizophrenia. Biol Psychiatry 60: 1224–1230.
4. Artavanis-Tsakonas S. Simpson P. (1991) Choosing a cell fate: a view from the Notch locus. Trends Genet 7: 403–408.
5. Ashur-Fabian O. Segal-Ruder Y. Skutelsky E. Brenneman D. Steingart R. Giladi E. et al. (2003) The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide. Peptides 24: 1413–1423.
6. Berezovska O. McLean P. Knowles R. Frosh M. Lu F. Lux S. et al. (1999) Notch 1 inhibits neurite outgrowth in postmitotic primary neurons. Neuroscience 93: 433–439.
7. Berezovska O. Xia M. Hyman B. (1998) Notch is expressed in adult brain, is coexpressed with presenilin-1, and is altered in Alzheimer disease. J Neuropathol Exp Neurol 57: 738–745.
8. Bonini S. Ferrari-Toninelli G. Uberti D. Montinaro M. Buizza L. Lanni C. et al. (2011) Nuclear factor κB-dependent neurite remodeling is mediated by Notch pathway. J Neurosci 31: 11697–11705.
9. Brennan K. Tateson R. Lewis K. Arias A. (1997) A functional analysis of Notch mutations in Drosophila. Genetics 147: 177–188.
10. Brunden K. Ballatore C. Lee V. Smith A. 3rd Trojanowski J. (2012) Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies. Biochem Soc Trans 40: 661–666.
11. Brunden K. Zhang B. Carroll J. Yao Y. Potuzak J. Hogan A. et al. (2010) Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy. J Neurosci 30: 13861–13866.
12. Bunker J. Wilson L. Jordan M. Feinstein S. (2004) Modulation of microtubule dynamics by tau in living cells: implications for development and neurodegeneration. Mol Biol Cell 15: 2720–2728.
13. Butler D. Bendiske J. Michaelis M. Karanian D. Bahr B. (2007) Microtubule-stabilizing agent prevents protein accumulation-induced loss of synaptic markers. Eur J Pharmacol 562: 20–27.
14. Cairns N. Lee V. Trojanowski J. (2004) The cytoskeleton in neurodegenerative diseases. J Pathol 204: 438–449.
15. Cappelletti G. Surrey T. Maci R. (2005) The parkinsonism producing neurotoxin MPP+ affects microtubule dynamics by acting as a destabilising factor. FEBS Lett 579: 4781–4786.
16. Cartelli D. Goldwurm S. Casagrande F. Pezzoli G. Cappelletti G. (2012) Microtubule destabilization is shared by genetic and idiopathic Parkinson's disease patient fibroblasts. PloS ONE 7: e37467.
17. Cartelli D. Ronchi C. Maggioni M. Rodighiero S. Giavini E. Cappelletti G. (2010) Microtubule dysfunction precedes transport impairment and mitochondria damage in MPP+ -induced neurodegeneration. J Neurochem 115: 247–258.
18. Ciani L. Salinas P. (2007) c-Jun N-terminal kinase (JNK) cooperates with Gsk3beta to regulate Dishevelled-mediated microtubule stability. BMC Cell Biol 8: 27.
19. Costa R. Honjo T. Silva A. (2003) Learning and memory deficits in Notch mutant mice. Curr Biol 13: 1348–1354.
20. de Paola V. Arber S. Caroni P. (2003) AMPA receptors regulate dynamic equilibrium of presynaptic terminals in mature hippocampal networks. Nat Neurosci 6: 491–500.
21. Dye C. Lee J. Atkinson R. Brewster R. Han P. Bellen H. (1998) The Drosophila sanpodo gene controls sibling cell fate and encodes a tropomodulin homolog, an actin/tropomyosin-associated protein. Development 125: 1845–1856.
22. Ehm O. Göritz C. Covic M. Schäffner I. Schwarz T. Karaca E. et al. (2010) RBPJkappa-dependent signaling is essential for long-term maintenance of neural stem cells in the adult hippocampus. J Neurosci 30: 13794–13807.
23. Errico A. Ballabio A. Rugarli E. (2002) Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics. Hum Mol Genet 11: 153–163.
24. Fassier C. Tarrade A. Peris L. Courageot S. Mailly P. Dalard C. et al. (2013) Microtubule- targeting drugs rescue axonal swellings in cortical neurons from Spastin knockout mice. Dis Model Mech 6: 72–83.
25. Ferrari-Toninelli G. Bernardi C. Quarto M. Lozza G. Memo M. Grilli M. (2003) Long-lasting induction of Notch 2 in the hippocampus of kainate-treated adult mice. Neuroreport 14: 917–921.
26. Ferrari-Toninelli G. Bonini S. Bettinsoli P. Uberti D. Memo M. (2008) Microtubule stabilizing effect of notch activation in primary cortical neurons. Neuroscience 154: 946–952.
27. Ferrari-Toninelli G. Bonini S. Uberti D. Napolitano F. Stante M. Santoro F. et al. (2009) Notch activation induces neurite remodeling and functional modifications in SH-SY5Y neuronal cells. Dev Neurobiol 69: 378–391.
28. Fouladi M. Stewart C. Olson J. Wagner L. Onar-Thomas A. Kocak M. et al. (2011) Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study. J Clin Oncol 29: 3529–3534.
29. Giniger E. (1998) A role for Abl in Notch signaling. Neuron 20: 667–681.
30. Giniger E. Jan L. Jan Y. (1993) Specifying the path of the intersegmental nerve of the Drosophila embryo: a role for Delta and Notch. Development 117: 431–440.
31. Go M. Eastman D. Artavanis-Tsakonas S. (1998) Cell proliferation control by Notch signaling in Drosophila development. Development 125: 2031–2040.
32. Goodin S. Kane M. Rubin E. (2004) Epothilones: mechanism of action and biologic activity. J Clin Oncol 22: 2015–2025.
33. Gouveia S. Akhmanova A. (2010) Cell and molecular biology of microtubule plus end tracking proteins: end binding proteins and their partners. Int Rev Cell Mol Biol 285: 1–74.
34. Gozes I. (2011) Microtubules (tau) as an emerging therapeutic target: NAP (davunetide). Curr Pharm Des 17: 3413–3417.
35. Gozes I. Alcalay R. Giladi E. Pinhasov A. Furman S. Brenneman D. (2002) NAP accelerates the performance of normal rats in the water maze. J Mol Neurosci 19(1-2): 167-170.
36. Gozes I. Giladi E. Pinhasov A. Bardea A. Brenneman D. (2000) Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze. J Pharmacol Exp Ther 293: 1091–1098.
37. Gozes I. Stewart A. Morimoto B. Fox A. Sutherland K. Schmeche D. (2009) Addressing Alzheimer's disease tangles: from NAP to AL-108. Curr Alzheimer Res 6: 455–460.
38. Greenblatt D. Vaccaro A. Jaskula-Sztul R. Ning L. Haymart M. Kunnimalaiyaan M. et al. (2007) Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells. Oncologist 12: 942–951.
39. Greenwald I. Rubin G. (1992) Making a difference: the role of cell-cell interactions in establishing separate identities for equivalent cells. Cell 68: 271–281.
40. Grilli M. Ferrari-Toninelli G. Uberti D. Spano P. Memo M. (2003) Alzheimer's disease linking neurodegeneration with neurodevelopment. Funct Neurol 18: 145–148.
41. Hammond J. Cai D. Verhey K. (2008) Tubulin modifications and their cellular functions. Curr Opin Cell Biol 20: 71–76.
42. Han H. Tanigaki K. Yamamoto N. Kuroda K. Yoshimoto M. Nakahata T. et al. (2002) Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. Int Immunol 14: 637–645.
43. Hassan B. Bermingham N. He Y. Sun Y. Jan Y. Zoghbi H. et al. (2000) Atonal regulates neurite arborization but does not act as a proneural gene in the Drosophila brain. Neuron 25: 549–561.
44. Hoppe P. Greenspan R. (1990) The Notch locus of Drosophila is required in epidermal cells for epidermal development. Development 109: 875–885.
45. Huang E. Li H. Tang A. Wiggins A. Neve R. Zhong W. et al. (2005) Targeted deletion of numb and numblike in sensory neurons reveals their essential functions in axon arborization. Genes Dev 19: 138–151.
46. Ittner L. Fath T. Ke Y. Bi M. van Eersel J. Li K. et al. (2008) Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia. Proc Natl Acad Sci U S A 105: 15997–16002.
47. Jablonka S. Wiese S. Sendtner M. (2004) Axonal defects in mouse models of motoneuron disease. J Neurobiol 58: 272–286.
48. Javitt D. Buchanan R. Keefe R. Kern R. McMahon R. Green M. et al. (2012) Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophr Res 136: 25–31.
49. Johnson M. Ables J. Eisch A. (2009) Cell-intrinsic signals that regulate adult neurogenesis in vivo: insights from inducible approaches. BMB Rep 42: 245–259.
50. Julien J. Millecamps S. Kriz J. (2005) Cytoskeletal defects in amyotrophic lateral sclerosis (motor neuron disease). Novartis Found Symp 264: 183–192; discussion 192–196, 227–230.
51. Kanaan N. Pigino G. Brady S. Lazarov O. Binder L. Morfini G. (2012) Axonal degeneration in Alzheimer's disease: when signaling abnormalities meet the axonal transport system. Exp Neurol 19 June (Epub ahead of print).
52. Kolman A. (2004) Epothilone D (Kosan/Roche). Curr Opin Investig Drugs 5: 657–667.
53. Kunnimalaiyaan M. Chen H. (2007) Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors. Oncologist 12: 535–542.
54. LaMonte B. Wallace K. Holloway B. Shelly S. Ascaño J. Tokito M. et al. (2002) Disruption of dynein / dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34: 715–727.
55. Lathia J. Mattson M. Cheng A. (2008) Notch: from neural development to neurological disorders. J Neurochem 107: 1471–1481.
56. Leker R. Teichner A. Grigoriadis N. Ovadia H. Brenneman D. Fridkin M. et al. (2002) NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death. Stroke 33: 1085–1092.
57. Louvi A. Artavanis-Tsakonas S. (2006) Notch signalling in vertebrate neural development. Nat Rev Neurosci 7: 93–102.
58. Maccioni R. Cambiazo V. (1995) Role of microtubule-associated proteins in the control of microtubule assembly. Physiol Rev 75: 835–864.
59. Major R. Irvine K. (2005) Influence of Notch on dorsoventral compartmentalization and actin organization in the Drosophila wing. Development 132: 3823–3833.
60. Matenia D. Mandelkow E. (2009) The tau of MARK: a polarized view of the cytoskeleton. Trends Biochem Sci 34: 332–342.
61. Matsuoka Y. Gray A. Hirata-Fukae C. Minami S. Waterhouse E. Mattson M. et al. (2007) Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stage. J Mol Neurosci 31: 165–170.
62. Menne T. Klämbt C. (1994) The formation of commissures in the Drosophila CNS depends on the midline cells and on the Notch gene. Development 120: 123–133.
63. Michaelis M. Ansar S. Chen Y. Reiff E. Seyb K. Himes R. et al. (2005) {beta}-Amyloid-induced neurodegeneration and protection by structurally diverse microtubule-stabilizing agents. J Pharmacol Exp Ther 312: 659–668.
64. Michaelis M. Chen Y. Hill S. Reiff E. Georg G. Rice A. et al. (2002) Amyloid peptide toxicity and microtubule-stabilizing drugs. J Mol Neurosci 19: 101–105.
65. Michaelis M. Seyb K. Ansar S. (2005) Cytoskeletal integrity as a drug target. Curr Alzheimer Res 2: 227–229.
66. Miele L. Miao H. Nickoloff B. (2006) NOTCH signaling as a novel cancer therapeutic target. Curr Cancer Drug Targets 6: 313–323.
67. Morfini G. Pigino G. Beffert U. Busciglio J. Brady S. (2002) Fast axonal transport misregulation and Alzheimer's disease. Neuromolecular Med 2: 89–99.
68. Mori D. Yamada M. Mimori-Kiyosue Y. Shirai Y. Suzuki A. Ohno S. et al. (2009) An essential role of the aPKC-Aurora A-NDEL1 pathway in neurite elongation by modulation of microtubule dynamics. Nat Cell Biol 11: 1057–1068.
69. Mórotz G. de Vos K. Vagnoni A. Ackerley S. Shaw C. Miller C. (2012) Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria. Hum Mol Genet 21: 1979–1988.
70. Moscarello M. Mak B. Nguyen T. Wood D. Mastronardi F. Ludwin S. (2002) Paclitaxel (Taxol) attenuates clinical disease in a spontaneously demyelinating transgenic mouse and induces remyelination. Mult Scler 8: 130–138.
71. Nelson R. (2005) Microtubule-stabilising drugs may be therapeutic in AD. Lancet Neurol 4: 83–84.
72. Nickoloff B. Osborne B. Miele L. (2003) Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene 22: 6598–6608.
73. Nikonenko I. Jourdain P. Muller D. (2003) Presynaptic remodeling contributes to activity-dependent synaptogenesis. J Neurosci 23: 8498–8505.
74. Pinchot S. Jaskula-Sztul R. Ning L. Peters N. Cook M. Kunnimalaiyaan M. et al. (2011) Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method. Cancer 117: 1386–1398.
75. Purow B. (2012) Notch inhibition as a promising new approach to cancer therapy. Adv Exp Med Biol 727: 305–319.
76. Qi H. Rand M. Wu X. Sestan N. Wang W. Rakic P. et al. (1999) Processing of the notch ligand delta by the metalloprotease Kuzbanian. Science 283: 91–94.
77. Rainier S. Jones S. Esposito C. Guice E. Otterud B. Leppert M. et al. (1998) Analysis of microtubule-associated protein 1a gene in hereditary spastic paraplegia. Neurology 51: 1509–1510.
78. Redmond L. Oh S. Hicks C. Weinmaster G. Ghosh A. (2000) Nuclear Notch 1 signaling and the regulation of dendritic development. Nat Neurosci 3: 30–40.
79. Reid E. Kloos M. Ashley-Koch A. Hughes L. Bevan S. Svenson I. et al. (2002) A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet 71: 1189–1194.
80. Roll-Mecak A. McNally F. (2010) Microtubule-severing enzymes. Curr Opin Cell Biol 22: 96–103.
81. Roy S. Zhang B. Lee V. Trojanowski J. (2005) Axonal transport defects: a common theme in neurodegenerative diseases. Acta Neuropathol 109: 5–13.
82. Salama-Cohen P. Arévalo M. Grantyn R. Rodríguez-Tébar A. (2006) Notch and NGF/p75NTR control dendrite morphology and the balance of excitatory / inhibitory synaptic input to hippocampal neurones through Neurogenin 3. J Neurochem 97: 1269–1278.
83. Santos L. León-Galván M. Marino-Marmolejo E. (2006) Notch signaling pathway and new strategies in cancer treatment. Salud Publica Mex 48: 155–165.
84. Schiff P. Fant J. Horwitz S. (1979) Promotion of microtubule assembly in vitro by taxol. Nature 277: 665–667.
85. Schofield A. Steel R. Bernard O. (2012) ROCK controls microtubule dynamics in a novel signaling pathway that regulates cell migration. J Biol Chem 287: 43620–43629.
86. Schuyler S. Pellman D. (2001) Microtubule ‘plus-end-tracking proteins’: the end is just the beginning. Cell 105: 421–424.
87. Sengottuvel V. Leibinger M. Pfreimer M. Andreadaki A. Fischer D. (2011) Taxol facilitates axon regeneration in the mature CNS. J Neurosci 31: 2688–2699.
88. Sestan N. Artavanis-Tsakonas S. Rakic P. (1999) Contact-dependent inhibition of cortical neurite growth mediated by notch signaling. Science 286: 741–746.
89. Sharma A. Paranjape A. Rangarajan A. Dighe R. (2012) A monoclonal antibody against human Notch 1 ligand-binding domain depletes subpopulation of putative breast cancer stem-like cells. Mol Cancer Ther 11: 77–86.
90. Shemesh O. Spira M. (2011) Rescue of neurons from undergoing hallmark tau-induced Alzheimer's disease cell pathologies by the antimitotic drug paclitaxel. Neurobiol Dis 43: 163–175.
91. Sherwood N. Sun Q. Xue M. Zhang B. Zinn K. (2004) Drosophila spastin regulates synaptic microtubule networks and is required for normal motor function. PLoS Biol 2: e429.
92. Silva D. Esteves A. Arduino D. Oliveira C. Cardoso S. (2011) Amyloid-β-induced mitochondrial dysfunction impairs the autophagic lysosomal pathway in a tubulin dependent pathway. J Alzheimers Dis 26: 565–581.
93. Simon-Areces J. Membrive G. Garcia-Fernandez C. Garcia-Segura L. Arevalo M. (2010) Neurogenin 3 cellular and subcellular localization in the developing and adult hippocampus. J Comp Neurol 518: 1814–1824.
94. Skeath J. Doe C. (1998) Sanpodo and Notch act in opposition to Numb to distinguish sibling neuron fates in the Drosophila CNS. Development 125: 1857–1865.
95. Tanabe K. Takei K. (2009) Dynamic instability of microtubules requires dynamin 2 and is impaired in a Charcot-Marie-Tooth mutant. J Cell Biol 185: 939–948.
96. Tanveer R. Gowran A. Noonan J. Keating S. Bowie A. Campbell V. (2012) The endocannabinoid, anandamide, augments Notch-1 signaling in cultured cortical neurons exposed to amyloid-β and in the cortex of aged rats. J Biol Chem 287: 34709–34721.
97. Tarrade A. Fassier C. Courageot S. Charvin D. Vitte J. Peris L. et al. (2006) A mutation of spastin is responsible for swellings and impairment of transport in a region of axon characterized by changes in microtubule composition. Hum Mol Genet 15: 3544–3558.
98. Terry R. (1998) The cytoskeleton in Alzheimer disease. J Neural Transm Suppl 53: 141–145.
99. Trojanowski J. Smith A. Huryn D. Lee V. (2005) Microtubule-stabilising drugs for therapy of Alzheimer's disease and other neurodegenerative disorders with axonal transport impairments. Expert Opin Pharmacother 6: 683–686.
100. Trotta N. Orso G. Rossetto M. Daga A. Broadie K. (2004) The hereditary spastic paraplegia gene, spastin, regulates microtubule stability to modulate synaptic structure and function. Curr Biol 14: 1135–1147.
101. Trushina E. Heldebrant M. Perez-Terzic C. Bortolon R. Kovtun I. Badger J. 2nd et al. (2003) Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease. Proc Natl Acad Sci U S A 100: 12171–12176.
102. Udo H. Jin I. Kim J. Li H. Youn T. Hawkins R. et al. (2005) Serotonin-induced regulation of the actin network for learning-related synaptic growth requires Cdc42, N-WASP, and PAK in Aplysia sensory neurons. Neuron 45: 887–901.
103. Umeda T. Ebihara T. Okabe S. (2005) Simultaneous observation of stably associated presynaptic varicosities and postsynaptic spines: morphological alterations of CA3-CA1 synapses in hippocampal slice cultures. Mol Cell Neurosci 28: 264–274.
104. Verhey K. Gaertig J. (2007) The tubulin code. Cell Cycle 6: 2152–2160.
105. Wersinger C. Sidhu A. (2005) Disruption of the interaction of alpha-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter. Biochemistry 44: 13612–13624.
106. Woo H. Park J. Gwon A. Arumugam T. Jo D. (2009) Alzheimer's disease and Notch signaling. Biochem Biophys Res Commun 390: 1093–1097.
107. Wood J. Landers J. Bingley M. McDermott C. Thomas-McArthur V. Gleadall L. et al. (2006) The microtubule-severing protein Spastin is essential for axon outgrowth in the zebrafish embryo. Hum Mol Genet 15: 2763–2771.
108. Yenjerla M. LaPointe N. Lopus M. Cox C. Jordan M. Feinstein S. et al. (2010) The neuroprotective peptide NAP does not directly affect polymerization or dynamics of reconstituted neural microtubules. J Alzheimers Dis 19: 1377–1386.
109. Yoon K. Gaiano N. (2005) Notch signaling in the mammalian central nervous system: insights from mouse mutants. Nat Neurosci 8: 1411.
110. Yu W. Qiang L. Solowska J. Karabay A. Korulu S. Baas P. (2008) The microtubule-severing proteins spastin and katanin participate differently in the formation of axonal branches. Mol Biol Cell 19: 1485–1498.
111. Zhang B. Carroll J. Trojanowski J. Yao Y. Iba M. Potuzak J. et al. (2012) The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice. J Neurosci 32: 3601–3611.
112. Zhang B. Maiti A. Shively S. Lakhani F. McDonald-Jones G. Bruce J. et al. (2005) Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. Proc Natl Acad Sci U S A 102: 227–231.
113. Zhao C. Takita J. Tanaka Y. Setou M. Nakagawa T. Takeda S. et al. (2001) Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105: 587–597.